- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 19.12.25 | MIRIS HOLDING: Miris AB Signs Distribution Agreement with Almazar Medical Corp to Expand Its Presence in the Middle East | 2 | Cision News | ||
| 31.10.25 | XFRA NEW INSTRUMENTS AVAILABLE ON 31.10.2025 | 403 | Xetra Newsboard | The following instruments on XETRA do have their first trading 31.10.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 31.10.2025
Aktien
1 US6391931010 Navan Inc.
2 US9509151083... ► Artikel lesen | |
| 30.10.25 | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 30.10.2025 | 949 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 30.10.2025Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 30.10.2025ISIN NameCA30222R1091 EXRO... ► Artikel lesen | |
| 30.10.25 | XFRA ISIN CHANGE | 396 | Xetra Newsboard | Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: AnmerkungenSE0015657820 Miris Holding AB 30.10.2025 SE0026821373 Miris Holding AB 31.10.2025 Tausch 500:1 ► Artikel lesen | |
| 30.10.25 | XFRA CAPITAL ADJUSTMENT INFORMATION - 30.10.2025 | 291 | Xetra Newsboard | Das Instrument 9W4 SE0015657820 MIRIS HOLDING AB O.N. EQUITY wird cum Kapitalmassnahme gehandelt am 30.10.2025 und ex Kapitalmassnahme am 31.10.2025 The instrument 9W4 SE0015657820 MIRIS HOLDING AB... ► Artikel lesen | |
| 27.10.25 | Spotlight Stock Market: Market Notice 194/25 - Information regarding the reverse split and changed ISIN for Miris Holding AB | 2 | Cision News | ||
| 08.09.25 | Spotlight Stock Market: Market Notice 168/25- Last day of trading in Miris Holding AB's subscription option MIR TO 3 | 1 | Cision News | ||
| MIRIS HOLDING Aktie jetzt für 0€ handeln | |||||
| 14.07.25 | Spotlight Stock Market: Market Notice 139/25 - Last day of trading in Miris Holding AB's BTA | 1 | Cision News | ||
| 09.06.25 | XFRA CAPITAL ADJUSTMENT INFORMATION - 09.06.2025 | 834 | Xetra Newsboard | Das Instrument 9W4 SE0015657820 MIRIS HOLDING AB O.N. EQUITY wird cum Kapitalmassnahme gehandelt am 09.06.2025 und ex Kapitalmassnahme am 10.06.2025 The instrument 9W4 SE0015657820 MIRIS HOLDING AB... ► Artikel lesen |
9 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BRIGHTSPRING HEALTH SERVICES | 39,510 | 0,00 % | S&P Dow Jones Indices: BrightSpring Health Services Set to Join S&P SmallCap 600 | NEW YORK, Oct. 14, 2025 /PRNewswire/ -- BrightSpring Health Services Inc. (NASD: BTSG) will replace Veritex Holdings Inc. (NASD: VBTX) in the S&P SmallCap 600 effective... ► Artikel lesen | |
| PROGYNY | 26,800 | 0,00 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 24,200 | 0,00 % | Citizens reiterates Market Outperform rating on Privia Health stock | ||
| PROCEPT BIOROBOTICS | 33,920 | 0,00 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 45,980 | -0,71 % | DEUTSCHE BANK RESEARCH stuft Siemens Healthineers auf 'Hold' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für Siemens Healthineers auf "Hold" mit einem Kursziel von 46 Euro belassen. Er rechne damit, dass der Start in das neue Geschäftsjahr... ► Artikel lesen | |
| GENEDX | 136,55 | +0,55 % | GeneDx to launch whole genome sequencing test for fetal anomalies | ||
| HEARTFLOW | 32,580 | 0,00 % | Heartflow, Inc.: Heartflow FFRCT Analysis Delivers Prognostic Power and Significant Cost Savings in New Analyses of Over 90,000 Patients with Coronary Artery Disease | Lesion-specific FFRCT predicts individual cardiovascular outcomes and delivers greater-than-modeled cost savings for real-world population in FISH&CHIPS analyses from England's National Health ServiceMOUNTAIN... ► Artikel lesen | |
| BETA BIONICS | 31,490 | 0,00 % | Beta Bionics, Inc.: Beta Bionics Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Guidance | IRVINE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| FRESENIUS | 49,460 | +1,00 % | Amneal Pharma, MAbxience: FDA Approves Denosumab Biosimilars Referencing Amgen's Prolia And XGEVA | THOUSAND OAKS (dpa-AFX) - Amneal Pharmaceuticals, Inc. (AMRX) announced late Monday that the U.S. Food and Drug Administration has approved the Biologics Licensing Applications or BLAs for Boncresa... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 7,300 | 0,00 % | LifeStance Health Group, Inc.: LifeStance Reports Third Quarter 2025 Results | SCOTTSDALE, Ariz., Nov. 06, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 38,680 | -1,28 % | Morgen-Update: Fresenius Medical Care sorgt für Schockwelle - Experten warnen vor weiterem Absturz! | ||
| BILLIONTOONE | 89,44 | 0,00 % | BillionToOne, Inc.: BillionToOne Reports Third Quarter 2025 Results | MENLO PARK, Calif., Dec. 09, 2025 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 8,870 | 0,00 % | Aveanna Healthcare Holdings, Inc: Aveanna Healthcare Holdings Announces Third Quarter Financial Results and Revised 2025 Outlook | Third Quarter Revenue was $621.9 million, a 22.2% increase over the prior year periodThird Quarter Net income was $14.1 million compared to Net loss of $42.8 million for the prior year periodAdjusted... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 20,925 | 0,00 % | Where Alignment Healthcare Stands With Analysts | ||
| LUMEXA IMAGING | 17,320 | 0,00 % | Lumexa Imaging Draws Bullish Analyst Calls On Heels Of IPO |
Das Unternehmen MIRIS HOLDING AB kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 2,660 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu MIRIS HOLDING AB finden Sie auf Wallstreet Online.